Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > so here are your 5 and 1 year returns on Antibe

<< Previous

Bullboard Posts

Next >>

Post by woundedkneeon Oct 22, 2021 3:36pm

313 Views

Post# 34038848

so here are your 5 and 1 year returns on Antibe

This of course if you have been holding and adding on the dips like Mr.Mugsey. lol 5 year -50.6% and 1 year -73.8%. One has to wonder why anyone would take his advice, seeing the results over the last 5 years. Now I don't mean this as an insult to Mugsy, but you would have to be pretty naive to think he didn't take some profits along the way. If not, I can certainly understand why Mrs. Mugsy would be so pissed off. lol

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"